Intelligence · Clinical Pipeline
Jazz Pharmaceuticals Ireland Pipeline
All ClinicalTrials.gov programs at Jazz Pharmaceuticals Ireland — phase, modality, and trial IDs.
- Programs
- 58
Quick answer
Jazz Pharmaceuticals Ireland has 58 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Xyrem
Jazz Pharmaceuticals Ireland Limited
Narcolepsy With Cataplexy
1 trial -
Xyrem
Jazz Pharmaceuticals Ireland Limited
Narcolepsy
1 trial -
Xyrem (sodium oxybate) oral solution
Jazz Pharmaceuticals Ireland Limited
Narcolepsy
1 trial -
Xyrem®
Jazz Pharmaceuticals Ireland Limited
Fibromyalgia
2 trials -
Zanidatamab
Jazz Pharmaceuticals Ireland Limited
Metastatic HER2-positive Breast Cancer
1 trial -
Zanidatamab
Jazz Pharmaceuticals Ireland Limited
Biliary Tract Cancer
1 trial -
a benzodiazepine drug
Jazz Pharmaceuticals Ireland Limited
Anxiety Disorder
1 trial -
experimental anti-anxiety drug
Jazz Pharmaceuticals Ireland Limited
Anxiety Disorder
1 trial -
placebo
Jazz Pharmaceuticals Ireland Limited
Fibromyalgia
1 trial -
supersaturated calcium-phosphate
Jazz Pharmaceuticals Ireland Limited
Oral Complaints
1 trial
Frequently asked questions
How many pipeline programs does Jazz Pharmaceuticals Ireland have?
58 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs